Guide to Gamma-Glutamyl Transferase (GGT)

WRITTEN BY

Updated: 05/22/2025|12 min read

Summary

Gamma-glutamyl transferase (GGT) is an enzyme primarily found in the liver, but also present in the kidneys, bile ducts, pancreas, heart, and other organs.

Why It Matters

GGT plays a key role in the metabolism of glutathione, the body's primary antioxidant. It helps transfer gamma-glutamyl groups from glutathione to other molecules.

When measured in the blood, GGT serves as a sensitive marker of liver health. When liver cells are damaged or bile flow is obstructed, GGT is released into the bloodstream, causing elevated levels.

However, GGT is more than just a liver marker. Research has increasingly recognized it as an important indicator of metabolic health and oxidative stress throughout the body. Elevated GGT, sometimes even within the upper end of the normal range, can be associated with increased risk of cardiovascular disease, Type 2 diabetes, metabolic syndrome, and all-cause mortality.

GGT is highly sensitive to alcohol consumption and certain medications, making it useful for monitoring their effects. Additionally, GGT helps differentiate between various causes of liver dysfunction, as patterns of elevation differ between alcoholic liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), biliary obstruction, and other conditions.

Associated Symptoms

GGT levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health conditions, each with its own symptoms.

Common symptoms that may indicate conditions associated with elevated GGT:

Fatigue: General tiredness and lack of energy may be related to liver stress and compromised metabolic function
Abdominal discomfort: Pain or tenderness in the upper right quadrant of the abdomen, potentially reflecting liver inflammation or bile duct issues
Jaundice: Yellowing of skin and eyes due to bilirubin buildup can occur when bile flow is impaired
Changes in urine or stool: Dark urine or light-colored stools may indicate altered bile processing and excretion
Itchy skin: Irritation caused by bile salts depositing in the skin can occur when bile flow is obstructed

Low GGT may be associated with B6 and/or magnesium deficiency, which come with their own potential side effects; B6 deficiency: skin rashes, mouth sores, neurological issues, and mood changesMagnesium deficiency: fatigue, muscle cramps or spasms, and weakness. More severe cases can involve heart rhythm problems, nausea, and even seizures. Having low-normal levels is considered beneficial and may reflect low oxidative stress and normal liver function.

It's important to understand that many people with elevated GGT, especially if it's only mildly elevated, may experience no symptoms at all. The presence of symptoms alongside abnormal GGT provides context for further investigation, but additional testing is typically needed to determine the underlying cause. GGT can serve as an early warning sign before noticeable symptoms develop, which makes it valuable for preventive health screening.

Clinical Ranges

Female:

16-19 Years: 6-26 U/L
20-29 Years: 3-40 U/L
30-39 Years: 3-50 U/L
40-49 Years: 3-55 U/L
50-59 Years: 3-70 U/L
≥60 Years: 3-65 U/L

Male:

16-19 Years: 9-31 U/L
20-29 Years: 3-70 U/L
30-39 Years: 3-90 U/L
40-54 Years: 3-95 U/L
55-59 Years: 3-85 U/L
≥60 Years: 3-70 U/L

Lifestyle Factors That Can Impact It

Factors that may increase GGT levels include the following:

Age
Regular alcohol consumption
High consumption of ultra-processed foods and added sugars
Smoking
Exposure to environmental toxins and heavy metals
Obesity, particularly central/visceral fat accumulation
Sedentary lifestyle
Chronic sleep deprivation
High dietary iron intake or consumption of iron supplements

Factors that may help lower elevated GGT levels include the following:

Whole food diet, like the Mediterranean, rich in fruits, vegetables, and olive oil
Weight loss if overweight or obese
Coffee consumption

Other Factors That Can Impact It

Medical Conditions

Metabolic dysfunction-associated steatotic liver disease (formerly known as non-alcoholic fatty liver disease): Increases GGT due to hepatocyte damage and oxidative stress
Hepatitis (viral or autoimmune): Typically elevates GGT along with other liver enzymes due to inflammatory liver and bile duct damage and oxidative stress
Biliary obstruction: Dramatically raises GGT levels as the enzyme backs up into the bloodstream when bile flow is blocked
Uncontrolled diabetes: Increases GGT through mechanisms related to insulin resistance and hepatic steatosis
Hyperthyroidism: Can elevate GGT due to increased metabolic rate and damage to the liver from unmet elevated oxygen demand

Medications

Anticonvulsants (phenytoin, carbamazepine): Increase GGT by increasing production of liver enzymes
Statins: Can cause modest GGT elevation in some people due to drug metabolism in the liver
Oral contraceptives: May increase GGT through effects on liver metabolism
Acetaminophen at high doses: Can raise GGT by depleting glutathione and causing liver damage and oxidative stress
Barbiturates(phenobarbital): Increase GGT through enzyme induction in the liver
Certain antibiotics and antifungals: Can raise GGT due to mild hepatotoxic effects

Testing Accuracy and Stability

Using alcohol, taking certain medications, and exercising can all influence GGT test results.

Factors That Can Affect the Accuracy of Your Test

Recent alcohol consumption can increase measured levels for at least 24 hours, potentially leading to elevated results.
Taking enzyme-inducing drugs within 1--2 weeks before testing can cause particularly significant elevations.
Recent intense exercise can temporarily increase levels due to muscle breakdown and oxidative stress.

How It Relates to Other Markers

Other tests can provide insights about health status when they're viewed alongside GGT results. These tests may include:

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) liver enzymes: Elevated GGT with normal ALT/AST may suggest early liver stress, biliary issues, or medication or alcohol consumption, potentially indicating liver damage.
Alkaline phosphatase (ALP) enzyme: GGT elevation with high ALP can suggest a bile duct problem.
Glutathione: GGT is a key enzyme in the production of the antioxidant glutathione.
Triglycerides and blood glucose: GGT elevation with high triglycerides and fasting glucose may indicate metabolic syndrome, which increases diabetes risk.
Ferritin: Elevation of both GGT and ferritin (a protein that stores iron) can suggest increased oxidative stress and systemic inflammation.
Bilirubin: In most liver conditions, GGT rises before bilirubin (a waste product from red blood cell breakdown). Elevation of both may suggest more advanced biliary or liver disease.

What Results May Mean in the Context of Other Markers

Elevated GGT with normal other liver enzymes: Can be an early sign of liver stress, may be related to alcohol consumption, medication effects, or early fatty liver.
Elevated GGT with elevated ALT/AST: May suggest active liver cell damage; the ratio and degree of elevation help distinguish between alcoholic liver disease (GGT often disproportionately high) and viral hepatitis (AST/ALT often higher than GGT).
Elevated GGT with elevated ALP and normal ALT/AST: May suggest biliary obstruction or cholestasis.
Elevated GGT with elevated triglycerides, glucose, and blood pressure: May reflect a metabolic syndrome pattern.
Modestly elevated GGT with normal other markers but high alcohol intake: May reflect a pattern of regular alcohol consumption.
Low-normal GGT with otherwise normal liver function: May be associated with reduced cardiovascular risk; can reflect healthy liver function.

Follow-up Considerations

If GGT is outside of normal range, your provider may make some of the following recommendations. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May Be Appropriate

Normal levels: Annual screening with regular metabolic panels
Borderline high: Every 6 months
Elevated levels: Every 3--4 months during intervention
After alcohol cessation: 2--4 weeks to assess improvement
When starting potentially hepatotoxic medications: Baseline and then every 1--3 months

Additional Testing Your Doctor May Consider

Complete liver panel (ALT, AST, ALP, bilirubin)
Hepatitis serology if cause unclear
Abdominal ultrasound for significantly elevated levels
Alcohol biomarkers (CDT, MCV) if alcohol-related elevation suspected
Iron studies if hemochromatosis is a consideration

When Additional Care May Be Warranted

GGT >3 times upper limit of normal
Rapidly rising GGT levels
GGT elevation with symptoms of liver disease
Persistent elevation despite lifestyle modifications
GGT elevation with signs of biliary obstruction
Severely elevated GGT (>10 times normal) requires urgent evaluation

Bibliography

References

1. Koenig, Gregory, and Stephanie Seneff. "Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk." Disease Markers, vol. 2015, 2015, Article 818570. https://doi.org/10.1155/2015/818570.

2. Ndrepepa, Gjin, and Adnan Kastrati. "Gamma-Glutamyl Transferase and Cardiovascular Disease." Annals of Translational Medicine, vol. 4, no. 24, 2016, Article 481. https://doi.org/10.21037/atm.2016.12.27.

3. Whitfield, John B. "Gamma Glutamyl Transferase." Critical Reviews in Clinical Laboratory Sciences, vol. 38, no. 4, 2001, pp. 263--355. https://doi.org/10.1080/20014091084227.

4. Lee, Duk-Hee, et al. "Is Serum Gamma Glutamyltransferase a Marker of Oxidative Stress?" Free Radical Research, vol. 38, no. 6, 2004, pp. 535--539. https://doi.org/10.1080/10715760410001694026.

5. Targher, Giovanni. "Elevated Serum Gamma-Glutamyltransferase Activity Is Associated with Increased Risk of Mortality, Incident Type 2 Diabetes, Cardiovascular Events, Chronic Kidney Disease and Cancer -- A Narrative Review." Clinical Chemistry and Laboratory Medicine (CCLM), vol. 48, no. 2, 2010, pp. 147--157. https://doi.org/10.1515/CCLM.2010.031.

6. Chiyanika C, Shumbayawonda E, Pansini M, Liu KH, Yip TC, Wong VW, Chu WCW. Gamma-glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction-associated steatotic liver disease. Clin Obes. 2025 Feb;15(1):e12712. doi: 10.1111/cob.12712.

7. Mitrić A, Castellano I. Targeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis. Free Radic Biol Med. 2023 Nov 1;208:672-683. doi: 10.1016/j.freeradbiomed.2023.09.020.

8. Marí M, Morales A, Colell A, García-Ruiz C, Fernández-Checa JC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal. 2009 Nov;11(11):2685-700. doi: 10.1089/ARS.2009.2695.

9. Xing, Mindan MSa; Gao, Min MSb; Li, Jia MDa,b,∗; Han, Ping MSb; Mei, Ling MSc; Zhao, Lili MDb. Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases. Medicine 101(1):p e28443, January 07, 2022. | DOI: 10.1097/MD.0000000000028443

10. Xuan, Y., He, F., Liu, Q. et al. Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis. Sci Rep 15, 10 (2025). https://doi.org/10.1038/s41598-024-84649-w

11. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33. doi: 10.1161/01.ATV.0000251993.20372.40.

12. Onat A, Hergenç G, Karabulut A, Türkmen S, Doğan Y, Uyarel H, Can G, Sansoy V. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med. 2006 Aug;43(2):136-9. doi: 10.1016/j.ypmed.2006.04.005.

13. Gong S, Gan S, Zhang Y, Zhou H, Zhou Q. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2023 Oct 3;14:1248614. doi: 10.3389/fendo.2023.1248614.

14. Dhingra R, Gona P, Wang TJ, Fox CS, D'Agostino RB Sr, Vasan RS. Serum gamma-glutamyl transferase and risk of heart failure in the community. Arterioscler Thromb Vasc Biol. 2010 Sep;30(9):1855-60. doi: 10.1161/ATVBAHA.110.207340.

15. Haghighi S, Amini M, Pournaghshband Z, Amini P, Hovsepian S. Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients. J Res Med Sci. 2011 Feb;16(2):123-9.

16. Bi Y, Yang Y, Yuan X, Wang J, Wang T, Liu Z, Tian S, Sun C. Association between liver enzymes and type 2 diabetes: a real-world study. Front Endocrinol (Lausanne). 2024 Feb 20;15:1340604. doi: 10.3389/fendo.2024.1340604.

17. Cho EJ, Jeong SM, Chung GE, Yoo JJ, Cho Y, Lee KN, Shin DW, Kim YJ, Yoon JH, Han K, Yu SJ. Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study. Sci Rep. 2023 Jan 31;13(1):1751. doi: 10.1038/s41598-022-25970-0.

18. van Beek JHDA, de Moor MHM, Geels LM, Sinke MRT, de Geus EJC, Lubke GH, Kluft C, Neuteboom J, Vink JM, Willemsen G, Boomsma DI. The association of alcohol intake with γ-glutamyl transferase (GGT) levels: evidence for correlated genetic effects. Drug Alcohol Depend. 2014 Jan 1;134:99-105. doi: 10.1016/j.drugalcdep.2013.09.016.

19. Sueyoshi S, Sawai S, Satoh M, Seimiya M, Sogawa K, Fukumura A, Tsutsumi M, Nomura F. Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease. World J Hepatol. 2016 Dec 28;8(36):1610-1616. doi: 10.4254/wjh.v8.i36.1610.

20. Zhao L, Clay-Gilmour A, Zhang J, Zhang X, Steck SE. Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants. Am J Clin Nutr. 2024 Jan;119(1):49-57. doi: 10.1016/j.ajcnut.2023.10.014.

21. Zhang Z, Ma L, Geng H, Bian Y. Effects of Smoking, and Drinking on Serum Gamma-Glutamyl Transferase Levels Using Physical Examination Data: A Cross-Sectional Study in Northwest China. Int J Gen Med. 2021 Apr 15;14:1301-1309. doi: 10.2147/IJGM.S301900.

22. Wirsching J, Nagel G, Tsai MY, de Hoogh K, Jaensch A, Anwander B, Sokhi RS, Ulmer H, Zitt E, Concin H, Brunekreef B, Hoek G, Weinmayr G. Exposure to ambient air pollution and elevated blood levels of gamma-glutamyl transferase in a large Austrian cohort. Sci Total Environ. 2023 Jul 20;883:163658. doi: 10.1016/j.scitotenv.2023.163658.

23. Li W, Li X, Su J, Chen H, Zhao P, Qian H, Gao X, Ye Q, Zhang G, Li X. Associations of blood metals with liver function: Analysis of NHANES from 2011 to 2018. Chemosphere. 2023 Mar;317:137854. doi: 10.1016/j.chemosphere.2023.137854.

24. Milnerowicz H, Bizoń A, Stasiak K. Aktywność gamma-glutamylotransferazy we krwi palacych i niepalacych hutników [Activity of gamma-glutamyltransferase in blood of smoking and non-smoking smelters]. Przegl Lek. 2010;67(10):910-3.

25. Li J, Hua S, Chen GC, Strizich G, Kuniholm MH, Shan Z, Talavera GA, Castañeda SF, Gellman MD, Cai J, Cotler SJ, Zhang X, Hu FB, Kaplan R, Isasi CR, Qi Q. Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. Liver Int. 2020 Aug;40(8):1883-1894. doi: 10.1111/liv.14514.

26. Li Q, Zhang S, Wang H, Xue C, Zhang X, Qin S, Yuan J. Rotating night shift work, sleep duration and elevated gamma-glutamyl transpeptidase among steelworkers: cross-sectional analyses from a Chinese occupational cohort. BMJ Open. 2021 Dec 15;11(12):e053125. doi: 10.1136/bmjopen-2021-053125.

27. Wong TY, Travis RC, Tong TYN. Blood biomarker levels by total sleep duration: cross-sectional analyses in UK Biobank. Sleep Med. 2021 Dec;88:256-261. doi: 10.1016/j.sleep.2021.10.018.

28. Nanri H, Hara M, Nishida Y, Shimanoe C, Nakamura K, Higaki Y, Imaizumi T, Taguchi N, Sakamoto T, Horita M, Shinchi K, Kokaze A, Tanaka K. Dietary patterns and serum gamma-glutamyl transferase in Japanese men and women. J Epidemiol. 2015;25(5):378-86. doi: 10.2188/jea.JE20140158.

29. Sangouni AA, Hassani Zadeh S, Mozaffari-Khosravi H, Hosseinzadeh M. Effect of Mediterranean diet on liver enzymes: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition. 2022;128(7):1231-1239. doi:10.1017/S0007114521002270

30. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006 Oct;16(10):1278-86. doi: 10.1381/096089206778663805.

31. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol. 1998 Jun;27(3):438-43. doi: 10.1093/ije/27.3.438.

32. Chen LW, Huang MS, Shyu YC, Chien RN. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study. Kaohsiung J Med Sci. 2021 Sep;37(9):819-827. doi: 10.1002/kjm2.12395.

33. Singh J, Jones G, Mahan D. A case of idiopathic GGT elevation with acute hepatitis A. J Family Med Prim Care. 2019 Jul;8(7):2542-2544. doi: 10.4103/jfmpc.jfmpc_342_19.

34. Opoku-Akyeampong NAAS, Agyei-Nkansah A, Yorke E. Liver dysfunction associated with hyperthyroidism: Lessons from 2 Case reports. Clin Case Rep. 2021 Mar 16;9(6):e04067. doi: 10.1002/ccr3.4067.

35. Maan JS, Duong TvH, Saadabadi A. Carbamazepine. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482455/

36. Braide SA, Davies TJ. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs. Ann Clin Biochem. 1987 Jul;24 ( Pt 4):391-9. doi: 10.1177/000456328702400408

37. Xu, Yan MD, PhD; Wu, Yanqing MD, PhD∗. Atorvastatin associated with gamma glutamyl transpeptidase elevation in a hyperlipidemia patient: A case report and literature review. Medicine 99(40):p e22572, October 02, 2020.

38. Naz F, Jyoti S, Rahul, Akhtar N, Siddique YH. Effect of Oral Contraceptive Pills on the Blood Serum Enzymes and DNA Damage in Lymphocytes Among Users. Indian J Clin Biochem. 2016 Jul;31(3):294-301. doi: 10.1007/s12291-015-0533-x.

39. Li X, Ni J, Chen L. Advances in the study of acetaminophen-induced liver injury. Front Pharmacol. 2023 Aug 4;14:1239395. doi: 10.3389/fphar.2023.1239395. Erratum in: Front Pharmacol. 2023 Sep 21;14:1283596. doi: 10.3389/fphar.2023.1283596.

40. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Barbiturates. [Updated 2021 Oct 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548260/

41. Spernovasilis N, Kofteridis DP. Pre-Existing Liver Disease and Toxicity of Antifungals. J Fungi (Basel). 2018 Dec 10;4(4):133. doi: 10.3390/jof4040133.

42. Franzini M, Scataglini I, Ricchiuti A, Fierabracci V, Paolicchi A, Pompella A, Dell'Omo G, Pedrinelli R, Corti A. Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients. Sci Rep. 2017 Sep 20;7(1):12003. doi: 10.1038/s41598-017-12356-w.

43. Mohapatra E, Priya R, Nanda R, Patel S. Serum GGT and serum ferritin as early markers for metabolic syndrome. J Family Med Prim Care. 2020 Jul 30;9(7):3458-3463. doi: 10.4103/jfmpc.jfmpc_570_20.

44. Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, Hall R, Harrower U, Hudson M, Langford A, Mackie A, Mitchell-Thain R, Sennett K, Sheron NC, Verne J, Walmsley M, Yeoman A. Guidelines on the management of abnormal liver blood tests. Gut. 2018 Jan;67(1):6-19. doi: 10.1136/gutjnl-2017-314924.

45. Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, Niemelä O. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol. 2009 Mar-Apr;44(2):199-203. doi: 10.1093/alcalc/agn099.

46. Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol. 2013 Winter;18(1):53-6.